Novo Nordisk A/S News Headlines

NVO 
$44.67
*  
0.21
0.47%
Get NVO Alerts
*Delayed - data as of Nov. 25, 2014  -  Find a broker to begin trading NVO now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NVO After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Is There Investment Upside In The Future Of Treating Diabetes?
2/10/2014 8:01:00 AM - Seeking Alpha


Novo-Nordisk As (NVO): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
2/10/2014 7:00:01 AM - Zacks.com


Update on Novo Nordisk's Diabetes Pipeline - Analyst Blog
2/7/2014 4:55:01 PM - Zacks.com


Novo Nordisk Gives anti-NKG2A Rights to Innate - Analyst Blog
2/6/2014 4:45:01 PM - Zacks.com


The Dream Of The Insulin Pill: Oramed Vs. Rivals
2/6/2014 6:51:00 AM - Seeking Alpha


European Shares Mixed, But Trade Cautious Ahead of US Jobs Data on Friday
2/5/2014 12:18:14 PM - MT Newswires


Weekly 52-Week Highs Highlight: ACT, NVO, NXPI, WYNN
2/3/2014 12:48:59 PM - GuruFocus


Novo Nordisk Beats on Q4 Earnings - Analyst Blog
1/31/2014 3:30:01 PM - Zacks.com


European Bourses Ease As Inflation Drop Ignites Worries of Deflation
1/31/2014 12:24:28 PM - MT Newswires


European Shares Mixed, Pare Early Losses Made on Weak China PMI and Fed Tapering
1/30/2014 12:19:53 PM - MT Newswires


CHMP Positive on Glaxo's Eperzan - Analyst Blog
1/27/2014 6:30:01 PM - Zacks.com


Amgen: The Best Value In Biotech
1/24/2014 10:45:00 AM - Seeking Alpha


Pre-Market Most Active for Jan 24, 2014 : AA, NOK, TS, MSFT, MT, NVO, LYG, QQQ, BBRY, ARIA, FB, XIV
1/24/2014 8:39:39 AM - NASDAQ.com News


EU Approval for AstraZeneca's Xigduo - Analyst Blog
1/23/2014 4:00:01 PM - Zacks.com


Novo Nordisk Launches NovoFine Plus - Analyst Blog
1/21/2014 6:50:01 PM - Zacks.com


Dividend Contenders: 34 Increases Expected In The Next 11 Weeks
1/17/2014 11:10:00 AM - Seeking Alpha


Sanofi's LixiLan Progresses - Analyst Blog
1/16/2014 6:20:01 PM - Zacks.com


Cramer's Lightning Round - TiVo's Downgrade Had Gravitas (1/14/13)
1/15/2014 6:01:00 AM - Seeking Alpha


Pre-Market Most Active for Jan 10, 2014 : NOK, BAC, AA, QQQ, TGT, INFY, NVO, CNAT, MNKD, FB, XIV, MSFT
1/10/2014 8:38:58 AM - NASDAQ.com News


Novo Nordisk A/S (NVO) Enters Overbought Territory - Tale of the Tape
1/6/2014 8:51:01 AM - Zacks.com


U.S. Approval for NVO's Tretten - Analyst Blog
12/27/2013 11:02:10 AM - Zacks.com


Arena Pharmaceuticals - A 2014 Story
12/26/2013 4:14:00 PM - Seeking Alpha


Update on NVO's Victoza - Analyst Blog
12/26/2013 12:10:01 PM - Zacks.com


The Obesity Drug Industry Going Into 2014
12/26/2013 6:24:00 AM - Seeking Alpha


Diabetes Programs Now Crucial For Eli Lilly
12/23/2013 8:15:00 AM - Seeking Alpha